je.st
news
Novartis agrees to sell its flu vaccine business to CSL of Australia for $275 million
2014-10-27 22:24:44| Biotech - Topix.net
CSL Ltd. said the deal will make it the second-largest flu vaccine maker in the world. The company said the Novartis business had $527 million in revenue in 2013 and said its combined revenue could reach $1 billion a year in three to five years.
Tags: business
sell
australia
million
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||